There are primarily two methods for evaluating antibody coverage: 2D Western blot or Antibody Affinity Extraction (AAE). In the production and purification of therapeutic recombinant proteins expressed by cultured mammalian cells, contamination by HCPs is a potential issue. Every validation and quality control test of therapeutic proteins should include an assay to demonstrate HCP contamination levels.
Quick Search
Products 
